enVVeno Medical Corporation (NVNO) Ownership
NVNO ownership summary
as of October 18, 2026- Institutions
- 16.0% of shares outstanding
- Insiders
- 8.23% of shares outstanding
- Shares outstanding
- 695K
- Float
- 590K shares available to trade
- Short interest
- 1.96% 14K shares short
- Days to cover
- 0.47 short interest up 44.1% vs prior month
- Institutions 15.96%
- Insiders 8.23%
- Other investors 75.82%
NVNO top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Kingdon Capital Management LLC | 5.21% | 36K | $270,160 | — | June 30, 2026 |
| 2 | CM Management, LLC | 5.14% | 36K | $266,784 | — | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 0.90% | 6,287 | $46,964 | — | June 30, 2026 |
| 4 | JPMorgan Chase & Co | 0.75% | 5,208 | $38,904 | −1 (−0.0%) | June 30, 2026 |
| 5 | Vanguard Fiduciary Trust Co | 0.31% | 2,184 | $16,314 | — | June 30, 2026 |
| 6 | Westside Investment Management, Inc. | 0.22% | 1,525 | $11,392 | −64 (−4.0%) | June 30, 2026 |
| 7 | Mirae Asset Global Investments (Korea) Co Ltd | 0.08% | 539 | $4,026 | +539 (0.0%) | June 30, 2026 |
| 8 | BlackRock Inc | 0.06% | 414 | $3,093 | −1,426 (−77.5%) | June 30, 2026 |
| 9 | Tower Research Capital LLC | 0.05% | 331 | $2,473 | −211 (−38.9%) | June 30, 2026 |
| 10 | Wells Fargo & Co | 0.02% | 114 | $852 | — | June 30, 2026 |
| 11 | Allied Private Wealth LLC | 0.01% | 88 | $657 | +88 (0.0%) | June 30, 2026 |
| 12 | Vanguard Global Advisers, LLC | 0.01% | 77 | $575 | — | June 30, 2026 |
| 13 | Morgan Stanley - Brokerage Accounts | 0.01% | 59 | $441 | −17 (−22.4%) | June 30, 2026 |
| 14 | Advisor Group Holdings, Inc. | <0.01% | 7 | $52 | — | June 30, 2026 |
| 15 | Barclays PLC | <0.01% | 2 | $15 | +2 (0.0%) | June 30, 2026 |
| 16 | Group One Trading, LLC | <0.01% | 2 | $15 | — | June 30, 2026 |
| 17 | UBS Group AG | <0.01% | 1 | $7 | −242 (−99.6%) | June 30, 2026 |
| 18 | Creative Planning Inc | 0.00% | — | — | −597 (−100.0%) | March 31, 2026 |
| 19 | State Street Corp | 0.00% | — | — | −1,166 (−100.0%) | March 31, 2026 |
| 20 | Susquehanna International Group, LLP | 0.00% | — | — | −3,781 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 3 holders added 629 shares and 9 cut 7,505.
NVNO top mutual fund and ETF holders
5 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.47% | 3,297 | $24,629 | −18 (−0.5%) | August 31, 2026 |
| 2 | Fidelity Total Market Index | 0.12% | 841 | $6,282 | — | August 31, 2026 |
| 3 | Fidelity Series Total Market Index | 0.12% | 805 | $6,013 | — | August 31, 2026 |
| 4 | Fidelity Nasdaq Composite Index | 0.03% | 176 | $1,315 | — | August 31, 2026 |
| 5 | Vanguard U.S. Eq Idx £ Acc | 0.01% | 77 | $575 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
NVNO insider transactions
latest 3| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-12 | Francis Duhay | Sell | $11.52 | 140 | $1,613 |
| 2025-12-11 | Francis Duhay | Sell | $12.60 | 140 | $1,764 |
| 2025-09-15 | Francis Duhay | Sell | $29.05 | 140 | $4,067 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
NVNO shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns NVNO
Institutional investors own 16.0% of enVVeno Medical's shares and insiders 8.23%. The largest holder is Kingdon Capital Management LLC with 5.21% of the shares (36K), as of June 30, 2026. Among the top 20 institutions, 3 added shares and 9 reduced their stake in the latest filings. Short interest is 1.96% of the float, or 0.47 days of average trading volume. The share count rose 8,150.0% since 2015.
Related: NVNO analyst forecast, NVNO key metrics. See the NVNO stock overview for the latest quote and news.
NVNO ownership FAQ
Who owns the most enVVeno Medical stock?
The largest shareholders of enVVeno Medical are Kingdon Capital Management LLC (5.21%), CM Management, LLC (5.14%), Vanguard Capital Management, LLC (0.90%), JPMorgan Chase & Co (0.75%), Vanguard Fiduciary Trust Co (0.31%).
What percentage of enVVeno Medical is owned by institutions?
Institutions hold 16.0% of enVVeno Medical's shares outstanding; insiders hold 8.23%.
Which funds own enVVeno Medical?
The largest fund holders of enVVeno Medical are Fidelity Extended Market Index (0.47%), Fidelity Total Market Index (0.12%), Fidelity Series Total Market Index (0.12%), Fidelity Nasdaq Composite Index (0.03%), Vanguard U.S. Eq Idx £ Acc (0.01%).
What is enVVeno Medical's short interest?
14K shares of enVVeno Medical were sold short, 1.96% of the float; at the average daily volume it would take 0.47 days to cover.
Are insiders buying or selling enVVeno Medical?
Of the latest 3 reported insider transactions in enVVeno Medical (since September 15, 2025), 0 were purchases and 3 were sales.
How many shares of enVVeno Medical are outstanding?
enVVeno Medical has 695K shares outstanding, of which 590K are in the public float.